NHTSA Report: Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users
About this document
- Layer
- attachment: a document a meeting packet links to
- Type as titled
- publication (kind from doc_type)
- File
- 3a0160e9792366039c4c24908c2d7e1cb47c0353 application/pdf
- Cases
About: Jaime Bermudez (case)
Table 5. Time (Minutes) from Crash to Blood Draw
| Transport Origin | Trauma Center | Medical Examiner | ||||||
|---|---|---|---|---|---|---|---|---|
| n | MDN | M (SD) | n | MDN | M (SD) | |||
| Direct from Scene | 5,292 | 45.0 | 50.8 | (31.5) | 858 | 1,263.5 | 1,544.7 | (1,213.8) |
| Transfer | 512 | 199.5 | 192.0 | (94.3) | n/a | n/a | n/a | n/a |
| Other/Unknown | 99 | 68.0 | 96.8 | (79.8) | n/a | n/a | n/a | n/a |
| Total | 5,903 | 47.0 | 63.8 | (58.0) | 858 | 1,263.5 | 1,544.7 | (1,213.8) |
Note: Counts exclude cases with insufficient time information to calculate a time from crash to blood draw. A total of 479 trauma center cases and 39 ME cases did not have time from crash to blood draw calculated.
A total of 479 trauma center cases that were included in the final analyses did not have enough data available to determine the time from crash to blood draw, but a review of other study information indicated there was a high likelihood the blood draw took place well within the 6- hour window from the crash. Similarly, ME cases included in the final analyses did not have sufficient time data available for calculation of time from crash to blood draw for 39 cases.
Materials
Blood Collection Tubes
Each tube was labeled with a unique study identification number and a corresponding barcode. Before the public health emergency began, blood samples at the trauma centers and MEs were collected in 6 mL gray-top BD Vacutainer tubes containing sodium fluoride (stabilizer) and potassium oxalate (anti-coagulant) to ensure drug stability in the uncoagulated blood. To ensure viable plasma could be obtained for COVID-19 antibody testing for trauma center cases for NIH's analytical purposes, the study protocol shifted to collecting samples at the trauma centers in 10 mL lavender-top BD Vacutainer tubes containing EDTA (anti-coagulant) during the public health emergency.6 Samples were then split with up to 6 mL of blood placed in a gray-top tube for toxicological analyses and the remainder processed for plasma for antibody testing by NIH. MEs continued to collect samples in the 6 mL gray-top tubes during the public health emergency.
Shipping Materials
All study shipping materials complied with the U.S. Department of Transportation and International Air Transport Association's (IATA) requirements for shipping biological substances, Category B (UN3373). Samples were first placed in containers designed for the transport of blood tubes. Absorbent material was placed around the samples in case of spillage. Containers that were not already 95kPa-rated were placed in a leak-proof 95kPa bag and sealed to prevent issues associated with pressure changes encountered during air transport at high altitudes. The container was placed in an insulated cooler and surrounded by gel refrigerant packs to maintain samples at a refrigerated temperature throughout shipping. The cooler was placed inside a box with DOT/IATA-compliant markings (Figure 1).
6 Gray-top tubes are generally not used when plasma is required for serological testing because the additives in the tube may interfere with test results. Using lavender-top tubes for initial sample collection allowed for the conduct of both the toxicology and serological testing with minimal impact on either set of results.
14
Keys: ← → or j k turn pages; / finds.